Emerging Pharmaceutical Market in India - Strategic Partnerships Between Domestic and International Pharmaceutical Players are the Driving Force - GBI Research Reports

Emerging Pharmaceutical Market in India - Strategic Partnerships Between Domestic and International Pharmaceutical Players are the Driving Force

Emerging Pharmaceutical Market in India - Strategic Partnerships Between Domestic and International Pharmaceutical Players are the Driving Force - GBI Research Reports
Emerging Pharmaceutical Market in India - Strategic Partnerships Between Domestic and International Pharmaceutical Players are the Driving Force
Published Aug 31, 2011
108 pages — Published Aug 31, 2011
Price US$ 3,500.00  |  Buy this Report Now

About This Report

  
Abstract:

Summary

GBI Researchs report, Emerging Pharmaceutical Market in India - Strategic Partnerships Between Domestic and International Pharmaceutical Players are the Driving Force, provides in-depth analysis of trends, issues and challenges in the Indian pharmaceutical industry. The report analyzes effective strategies adopted by industry participants that shape industry dynamics. Further, the report provides competitive benchmarking for the leading companies and analyzes the M&A and strategic partnerships that shape the Indian pharmaceutical market. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GBI Researchs team of industry experts.

Scope

The scope of this report includes -
- Overall pharma, biotech and outsourcing market structure.
- Market characterization, including market size
- CMO & CRO market size and growth
- Key drivers and barriers that have a significant impact on the market.
- Competitive benchmarking of leading companies.
- Key M&A activities and strategic partnership deals that have taken place in 2009

Reasons to buy

The report will enhance your decision making capability. It will allow you to -
- Align your product portfolio to the markets with high growth potential.
- Develop market-entry and market expansion strategies by identifying the leading therapeutic segments poised for strong growth.
- Device a more tailored country strategy through the understanding of key drivers and barriers of the countrys pharmaceutical market.
- Develop key strategic initiatives by understanding the key focus areas of leading companies.
- Accelerate and strengthen your market position by identifying key companies for mergers, acquisitions and strategic partnerships.

  
Source:
Document ID
GBIHC105MR
Industry
Format:
PDF Adobe Acrobat
Buy Now

Sections

TitleStarting PageNumber of Pages
Table of Contents36
  List of Tables61
  List of Figures72
Emerging Pharmaceutical Market: India Introduction91
  GBI Research Report Guidance91
Emerging Pharmaceutical Market: India Macroeconomic Environment106
  Demographic Analysis101
    Population Size, Growth, and Structure101
    Mortality Rate111
    Changes in Life Expectancy at Birth121
    Improved Child Survival131
  PESTLE Analysis141
    Political Factors141
    Economic Factors141
    Social Factors141
    Technological Factors151
    Legal151
    Environmental151
Emerging Pharmaceutical Market: India Industry Performance1614
  Macroeconomic Indicators161
  Population Profile161
    High Population and Economic Growth171
    Emergence of the Middle Class181
  Disease Profile181
    Shift in Disease Profile181
  Healthcare Expenditure191
  Healthcare Regulation201
    The Union Ministry of Health and Family Welfare (MoHFW)201
      Department of Health201
      Department of Family &Welfare201
      Department of AYUSH (Ayurveda, Yoga and Naturopathy, Unani, Siddha and Homoeopathy)211
      Autonomous Institutions Conducting Research and Development211
    National Programs and Schemes211
      National Rural Health Mission (NRHM)211
      National Health Policy 2002211
      Accreditation Schemes221
    Highlights of Budget 2010-2011231
      Other Government Initiatives231
    Health Insurance Regulation241
  Import &Exports241
    Imports241
    Exports251
    Top 10 Destinations of Indian Products261
  Branded &Generic Drugs271
    Peak Years of Patent Expiries to Bring Revenues to Indian Pharmaceutical Companies271
    Massive Decline in Sales of Big Pharma Companies281
  Skilled Manpower291
Emerging Pharmaceutical Market: India Pharmaceutical and Biotech Industry3049
  Introduction301
  Pharmaceutical Market Size and Growth in India301
    Domestic Market Size311
  Biotech Market Size in India321
  Pharmaceutical R&D in India321
    Forces that Drive Drug Discovery in India331
      Declining R&D Productivity, Especially for Big Pharma331
      Generics Competition Pricing Pressures on Branded Prescription Products342
  Key Pharmaceutical Regulations in India361
    The Central Drugs Standard Control Organization (CDSCO)361
    State Drug Regulatory Authority (SDRA)371
  Pricing and Reimbursement in India381
    Pricing of Pharmaceutical Drugs in India381
    Reimbursements of Pharmaceutical Drugs in India381
      Private Health Insurance391
      Health Insurance Companies Landscape393
  Intellectual Property Rights in India421
    Effect of Patent Laws on Pharmaceutical Production in India431
    Key Impact of the New Patent Laws on India441
    Patent Act 2005 First Step towards Improving IP Protection451
    IPR Enforcement Rules, 2007451
    Trademarks Bill 2007461
    Drugs and Cosmetics Act (Amendment) 2008461
    EIPR (Enforcers of Intellectual Property Rights) Ensuring IPR Laws Implementation in India471
      Case 1: BMS (Bristol-Myers Squibb) versus Hetero Drugs on Dasatinib471
      Case 2: Bayer versus Cipla on Nexavar471
      Case 3: Roche versus Cipla on Tarceva481
    Key Takeaways481
  Key Marketing and Distribution Channels in India491
  Mergers and Acquisitions501
    Deals by Year501
    Deals by Type511
    Deal by Value511
    Top 10 M&A Deals521
      Strides to Acquire 50% Stake in Onco Therapies and Onco Laboratories from Aspen531
      Mitsui to Acquire 5% Stake in Arch Pharmalabs531
      Biocon to Acquire Minority Stake in Biocon Biopharmaceuticals531
      UB Group Sells 10.27% Stake in Aventis Pharma to Hoechst531
      Sanofi-Aventis Acquires Majority Stake in Shantha Biotechnics531
      Daiichi Sankyo Acquires Majority Stake in Ranbaxy Laboratories541
      Arch Pharmalabs Acquires 70% Stake in Benzochem Lifesciences541
      Fresenius Kabi Acquires 90.9% Stake in Dabur Pharma541
      Ranbaxy Laboratories Acquires 25.15% Stake in Zenotech Laboratories541
      Aspen Pharmacare Acquires Stake in Onco Therapies from Strides Arcolab551
  Licensing Agreements551
    Deals by Year551
    Deals by Value561
    Key Takeaway561
    Top 10 Licensing Deals561
      Takeda Pharmaceutical Enters into Collaboration Agreement with Alnylam Pharmaceuticals561
      Algeta Signs Licensing Agreement with Bayer571
      BioInvent and ThromboGenics Enter into an Agreement with Roche571
      Sanofi-Aventis Enters into a Licensing Agreement with Merrimack Pharmaceuticals571
      Genentech Enters into Licensing Agreement with CGI Pharmaceuticals571
      Pfizer Enters into Licensing Agreement with Coley Pharmaceutical581
      Novacea Enters into Licensing Agreement with Schering-Plough for Asentar581
      Merck Enters into Licensing Agreement with Lpath581
      Merck Signs an Agreement with Idera Pharmaceuticals591
      Taiho Pharmaceutical Signs Licensing Agreement with Sanofi-Aventis591
  Key Players Foreign591
    Sanofi-Aventis591
      Company Overview591
      SWOT Analysis601
    F. Hoffmann-La Roche Ltd/Genentech, Inc.611
      Company Overview611
      SWOT Analysis612
    AstraZeneca631
      Company Overview631
      SWOT Analysis631
    GlaxoSmithKline641
      Company Overview641
      SWOT Analysis642
    Abbott Laboratories661
      Company Overview661
      SWOT Analysis662
  Key Players Domestic681
    Dr. Reddy s Lab681
      Company Overview681
      SWOT Analysis681
    Piramal Healthcare691
      Company Overview691
      SWOT Analysis701
    Biocon Limited711
      Company Overview711
      SWOT Analysis711
    Cipla Ltd.721
      Company Overview721
      SWOT Analysis721
    Ranbaxy Laboratories Limited731
      Company Overview731
      SWOT Analysis741
  Market Drivers751
    M&As Pick Up Speed751
    Established Generics Industry751
  Market Restraints751
    Weak Infrastructure751
    Financial Disparity751
    Intellectual Property (IP) Concerns761
      Unfavorable Patent Law for Bigger Companies761
    Effect of Counterfeit Medicines761
      Actions Taken By Indian Government against Counterfeit Drugs771
    Currency Fluctuation and Financial Problems will Make It Difficult to Sustain the Growth771
    Regulatory Hurdles781
  SWOT Analysis of Indian Pharmaceutical Sector781
Emerging Pharmaceutical Market: India Service Industries CMO, CRO7923
  CMO Market Size and Growth in India791
    Overview of Indian Contract Manufacturing Organization (CMO) Market791
  Key Players Domestic801
    Piramal Healthcare801
      Business Description801
    Jubilant Organosys801
      Business Description801
    BASF811
      Business Description811
  Key Players - Foreign811
    Lonza811
      Business Description811
    Evonik821
      Business Description821
    DSM821
      Business Description821
  CMO Market Drivers831
    Low-Cost Skilled Labor831
    Increase in Generics831
    Product Patent Regime831
    Vertically Integrated Business Model831
    Strategic Partnerships831
  CMO Market Restraints841
    Increasing Competition from China841
    Time-Consuming Development Periods841
    Need for Robust Execution Strategy841
    Poor Intellectual Property Protection and Regulatory Framework851
    Threat of Counterfeit Medicines Originating from India851
    Varied Compliance With cGMP Guidelines Across the Nation851
    High Effective Tax Rates851
  Clinical Research Organization (CRO) Market Size and Growth in India851
    Major CRO Locations in India861
    Clinical Trials Registered in 2009 in India862
  Key Players Foreign881
    Quintiles881
      Business Description881
    Paraxel881
      Business Description881
    Pharmaceutical Product Development (PPD) Inc.891
      Business Description891
  Key Players Domestic891
    SIRO Clinpharm Pvt Ltd891
      Business Description891
    Veeda Clinical Research Ltd901
      Business Description901
    GVK Biosciences Pvt Ltd911
      Business Description911
    Ecron Acunova921
      Business Description921
    Synchron Research Services Pvt Ltd931
      Business Description931
  CRO Market Drivers941
    High Risks and Costs Associated With Drug Development941
    Escalating Cost of Clinical Trials951
    Increase in Multinational Sites to Conduct Clinical Trials Will Drive the Clinical Trials Market in India961
    Increased Patient Availability due to Major Diseases971
    Global Increase in the Number of Clinical Trials Conducted971
    Restructuring the R&D981
    Increased Screening Rates During R&D991
    Expiring Patents Pressurize Pharmaceutical Companies to Reduce Costs991
  CRO Market Restraints991
    Lack of Training for Clinical Trial Professionals991
    Quality of Clinical Trial Data991
    ICH GCP vs. Indian GCP991
      Article 39.3 of TRIPS1001
    Ethical Issues1001
      Illegal and unethical Clinical Trials1001
      Slow Hiring in the Government Regulatory Bodies1001
    The Need for Proposed Additional Documents for Importing Drugs1011
  Major CRO Acquisitions1011
Emerging Pharmaceutical Market: India Health Care IT in India1022
  IT Outsourcing to India1021
  Cost of Setting Up A Clinical Data Management Setup In India1031
Emerging Pharmaceutical Market: India Appendix1045
  Market Definitions1041
  Abbreviations1042
  Research Methodology1062
    Macroeconomic Environment1061
    Industry Performance1061
    Pharmaceutical and Biotech Industry1071
    Service Industries CMO, CRO1071
    Health Care IT1071
  Contact Us1071
  Disclaimer1071
  Sources1081

Table Of Contents

GBI Research Reports—GBI Research covers worldwide markets and issues, supplies actionable data and forecasts and is driven by industry leaders' insights. GBI Research provides a broad spectrum of reports across the healthcare and energy industries and its online offering is easy to navigate - a comprehensive resource for business information needs.

About the Author


Cite this Report

  
MLA:
GBI Research Reports. "Emerging Pharmaceutical Market in India - Strategic Partnerships Between Domestic and International Pharmaceutical Players are the Driving Force" Aug 31, 2011. Alacra Store. Nov 16, 2026. <http://www.alacrastore.com/storecontent/GBI-Research-Reports/Emerging-Pharmaceutical-Market-in-India-Strategic-Partnerships-Between-Domestic-and-International-Pharmaceutical-Players-are-the-Driving-Force-2115-243>
  
APA:
GBI Research Reports. (2011). Emerging Pharmaceutical Market in India - Strategic Partnerships Between Domestic and International Pharmaceutical Players are the Driving Force Aug 31, 2011. New York, NY: Alacra Store. Retrieved Nov 16, 2026 from <http://www.alacrastore.com/storecontent/GBI-Research-Reports/Emerging-Pharmaceutical-Market-in-India-Strategic-Partnerships-Between-Domestic-and-International-Pharmaceutical-Players-are-the-Driving-Force-2115-243>
  
US$ 3,500.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our Market Research from one place.